1-5 of 5
Núria Malats
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B23: FGFR3 mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?

Bas van Rhijn, Laura Mertens, Roman Mayr, Peter Bostrom, Mirari Marques, Geert van Leenders, Stefanie Gotz, Michiel van der Heijden, Michael Jewett, Francisco Real, Robert Stohr, Alexandre Zlotta, Markus Eckstein, Yanish Soorojebally, Max Burger, Wolfgang Otto, Francois Radvanyi, Damien Pouessel, Theo van der Kwast, Nuria Malats, Arndt Hartmann, Yves Allory, Deric van der Schoot, Ellen Zwarthoff, Tahlita Zuiverloon
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (15_Supplement): B23.
https://doi.org/10.1158/1557-3265.BLADDER19-B23
Published: 03 August 2020
View article titled, Abstract B23: <em>FGFR3</em> mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?
Journal Articles

CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status

Carolina Rubio, Mónica Martínez-Fernández, Cristina Segovia, Iris Lodewijk, Cristian Suarez-Cabrera, Carmen Segrelles, Fernando López-Calderón, Ester Munera-Maravilla, Mirentxu Santos, Alejandra Bernardini, Ramón García-Escudero, Corina Lorz, Maria José Gómez-Rodriguez, Guillermo de Velasco, Irene Otero, Felipe Villacampa, Felix Guerrero-Ramos, Sergio Ruiz, Federico de la Rosa, Sara Domínguez-Rodríguez, Francisco X. Real, Núria Malats, Daniel Castellano, Marta Dueñas, Jesus M. Paramio
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 390–402.
https://doi.org/10.1158/1078-0432.CCR-18-0685
Published: 03 January 2019
View article titled, CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of <em>RB1</em> Status
Open the PDF for CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of <em>RB1</em> Status in another window
Includes: Supplementary data
Journal Articles

Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups

Kim E.M. van Kessel, Kirstin A. van der Keur, Lars Dyrskjøt, Ferran Algaba, Naeromy Y.C. Welvaart, Willemien Beukers, Ulrika Segersten, Bastian Keck, Tobias Maurer, Tatjana Simic, Marcus Horstmann, Marc-Oliver Grimm, Gregers G. Hermann, Karin Mogensen, Arndt Hartmann, Niels Harving, Astrid C. Petersen, Jørgen B. Jensen, Kerstin Junker, Joost L. Boormans, Francisco X. Real, Núria Malats, Per-Uno Malmström, Torben F. Ørntoft, Ellen C. Zwarthoff
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (7): 1586–1593.
https://doi.org/10.1158/1078-0432.CCR-17-2719
Published: 02 April 2018
View article titled, Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups
Open the PDF for Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups in another window
Includes: Supplementary data
Journal Articles

Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study

Maria Frantzi, Kim E. van Kessel, Ellen C. Zwarthoff, Mirari Marquez, Marta Rava, Núria Malats, Axel S. Merseburger, Ioannis Katafigiotis, Konstantinos Stravodimos, William Mullen, Jerome Zoidakis, Manousos Makridakis, Martin Pejchinovski, Elena Critselis, Ralph Lichtinghagen, Korbinian Brand, Mohammed Dakna, Maria G. Roubelakis, Dan Theodorescu, Antonia Vlahou, Harald Mischak, Nicholas P. Anagnou
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16): 4077–4086.
https://doi.org/10.1158/1078-0432.CCR-15-2715
Published: 14 August 2016
View article titled, Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
Open the PDF for Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study in another window
Includes: Supplementary data
Journal Articles

Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

Tomasz P. Radon, Nathalie J. Massat, Richard Jones, Wasfi Alrawashdeh, Laurent Dumartin, Darren Ennis, Stephen W. Duffy, Hemant M. Kocher, Stephen P. Pereira, Luisa Guarner (posthumous), Cristiane Murta-Nascimento, Francisco X. Real, Núria Malats, John Neoptolemos, Eithne Costello, William Greenhalf, Nick R. Lemoine, Tatjana Crnogorac-Jurcevic
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (15): 3512–3521.
https://doi.org/10.1158/1078-0432.CCR-14-2467
Published: 02 August 2015
View article titled, Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
Open the PDF for Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma in another window
Includes: Supplementary data